000 | 01437 a2200493 4500 | ||
---|---|---|---|
005 | 20250513122849.0 | ||
264 | 0 | _c19970919 | |
008 | 199709s 0 0 eng d | ||
022 | _a0390-6078 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZinzani, P L | |
245 | 0 | 0 |
_aPrimary intestinal lymphoma: clinical and therapeutic features of 32 patients. _h[electronic resource] |
260 |
_bHaematologica _c |
||
300 |
_a305-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aItaly _xepidemiology |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMagagnoli, M | |
700 | 1 | _aPagliani, G | |
700 | 1 | _aBendandi, M | |
700 | 1 | _aGherlinzoni, F | |
700 | 1 | _aMerla, E | |
700 | 1 | _aSalvucci, M | |
700 | 1 | _aTura, S | |
773 | 0 |
_tHaematologica _gvol. 82 _gno. 3 _gp. 305-8 |
|
999 |
_c9214690 _d9214690 |